Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension.
Halank
Michael
M
Miehlke
Stephan
S
Hoeffken
Gert
G
Schmeisser
Alexander
A
Schulze
Matthias
M
Strasser
Ruth H
RH
D000284:Administration, Oral; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000188:drug therapy*; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy*; D008297:Male; D013449:Sulfonamides / Q000008:administration & dosage*
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan